Clinical Trial: Hypercortisolism and Epicardial Adipose Tissue
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Impact Hypercortisolism on Adipose Epicardial and on Myocardial Function
Brief Summary: Identifying hypercortisolism patients at risk for cardio-vascular events despite biological cure, and determine which patients should be particularly followed. Hypercortisolic patients represent an ideal in vivo model to determine the interactions between glucocorticoids and ectopic fat development.
Detailed Summary:
Sponsor: Assistance Publique Hopitaux De Marseille
Current Primary Outcome:
- measuring the volume of epicardial adipose tissue, as measured by MRI to 3 Tesla. [ Time Frame: 36 months ]
- Assess insulin resistance by the blood sugar and insulin levels [ Time Frame: 36 months ]
- Assess cardiovascular risk by a blood complete lipid profile [ Time Frame: 36 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Assess insulin resistance by the blood leptin, adiponectin and omentin plasma level [ Time Frame: 36 months ]
- Assess cardiovascular risk by the blood leptin, adiponectin and omentin plasma level [ Time Frame: 36 months ]
Original Secondary Outcome: Same as current
Information By: Assistance Publique Hopitaux De Marseille
Dates:
Date Received: January 2, 2015
Date Started: December 2014
Date Completion:
Last Updated: January 7, 2015
Last Verified: January 2015
